CSIMarket Company Name, Ticker, Suppliers, else..
 
Emergent Biosolutions Inc   (NYSE: EBS)
 

Emergent Biosolutions Inc's Suppliers Performance

EBS's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
EBS Costs vs Sales of Suppliers Growth Emergent Biosolutions Inc recorded an increase in cost of sales by 45.14 % year on year, sequentially cost of sales grew by 34.86 % in Q2.

• More on EBS Suppliers



Emergent Biosolutions Inc recorded increase in cost of sales by 45.14 % year on year, sequentially cost of sales grew by 34.86 % in Q2.

• More on EBS Suppliers




Emergent Biosolutions Inc's Comment on Supply Chain


The company places purchase orders for raw materials and supplies in advance to meet demand. Materials undergo rigorous testing upon receipt. Alhydrogel® adjuvant 2%, used in CYFENDUS® and BioThrax® vaccines, is obtained from a single-source supplier with no alternative source, though stored supplies are maintained. Single-source suppliers are also used for other raw materials, all components of NARCAN® Nasal Spray, and plasma collection supporting CNJ-016® (VIGIV) and BAT® programs. The company maintains long-term agreements and works closely with these suppliers.

Emergent Biosolutions Inc's Comment on Supply Chain


The company places purchase orders for raw materials and supplies in advance to meet demand. Materials undergo rigorous testing upon receipt. Alhydrogel® adjuvant 2%, used in CYFENDUS® and BioThrax® vaccines, is obtained from a single-source supplier with no alternative source, though stored supplies are maintained. Single-source suppliers are also used for other raw materials, all components of NARCAN® Nasal Spray, and plasma collection supporting CNJ-016® (VIGIV) and BAT® programs. The company maintains long-term agreements and works closely with these suppliers.







EBS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Emergent Biosolutions Inc 344.17 770.20 -176.80 900
SUBTOTAL 0.00 0.00 0.00 -


Sources: Emergent Biosolutions Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Emergent Biosolutions Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.